Published in CMAJ on September 11, 2007
Finite element analysis applied to 3-T MR imaging of proximal femur microarchitecture: lower bone strength in patients with fragility fractures compared with control subjects. Radiology (2014) 2.15
Age-dependence of femoral strength in white women and men. J Bone Miner Res (2010) 2.03
GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int (2011) 1.43
Updated fracture incidence rates for the US version of FRAX. Osteoporos Int (2009) 1.40
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00
Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int (2014) 0.98
Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int (2008) 0.96
Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int (2014) 0.95
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2010) 0.93
High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int (2011) 0.92
A clinical decision rule to enhance targeted bone mineral density testing in healthy mid-life women. Osteoporos Int (2011) 0.91
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int (2014) 0.90
Quality of fracture risk assessment in post-fracture care in Ontario, Canada. Osteoporos Int (2012) 0.88
Increased microstructural variability is associated with decreased structural strength but with increased measures of structural ductility in human vertebrae. J Biomech Eng (2009) 0.87
7 Tesla MRI of bone microarchitecture discriminates between women without and with fragility fractures who do not differ by bone mineral density. J Bone Miner Metab (2014) 0.84
Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis. J Biomech (2012) 0.84
Stiffness of the endplate boundary layer and endplate surface topography are associated with brittleness of human whole vertebral bodies. Bone (2010) 0.83
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res (2013) 0.82
Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy. J Bone Miner Metab (2011) 0.82
Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT. Osteoporos Int (2014) 0.81
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81
Self-report of one-year fracture incidence and osteoporosis prevalence in a community cohort of canadians with spinal cord injury. Top Spinal Cord Inj Rehabil (2014) 0.81
Fracture predictive ability of physical performance tests and history of falls in elderly women: a 10-year prospective study. Osteoporos Int (2015) 0.79
A comparative study of using non-hip bone density inputs with FRAX®. Osteoporos Int (2011) 0.79
Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's disease. Dig Dis Sci (2012) 0.77
Haplotypes of intron 4 of the estrogen receptor alpha gene and hip fractures: a replication study in Caucasians. BMC Med Genet (2010) 0.77
Assessing the true impact of recurrent fractures on fracture risk. J Bone Miner Res (2009) 0.77
Fall-related injuries among Canadian seniors, 2005-2013: an analysis of the Canadian Community Health Survey. Health Promot Chronic Dis Prev Can (2015) 0.77
Quantitative assessment of trabecular bone micro-architecture of the wrist via 7 Tesla MRI: preliminary results. MAGMA (2011) 0.77
A study to evaluate the cause of bone demineralization in gynecological cancer survivors. Oncologist (2013) 0.77
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practice. Int J Womens Health (2016) 0.77
A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture. Osteoporos Int (2015) 0.77
Multisite quantitative ultrasound for the prediction of fractures over 5 years of follow-up: the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2013) 0.76
Prevalence of vertebral fracture in elderly men and women with osteopenia. Wien Klin Wochenschr (2009) 0.76
PUFAs, Bone Mineral Density, and Fragility Fracture: Findings from Human Studies. Adv Nutr (2016) 0.76
Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women. South Med J (2016) 0.76
In vivo measurement reproducibility of femoral neck microarchitectural parameters derived from 3T MR images. J Magn Reson Imaging (2015) 0.75
Study of DXA-derived lateral-medial cortical bone thickness in assessing hip fracture risk. Bone Rep (2015) 0.75
In vivo precision of three HR-pQCT-derived finite element models of the distal radius and tibia in postmenopausal women. BMC Musculoskelet Disord (2016) 0.75
PLCL1 rs7595412 variation is not associated with hip bone size variation in postmenopausal Danish women. BMC Med Genet (2009) 0.75
Zoledronic acid infusion for prevention and treatment of osteoporosis. Int J Womens Health (2010) 0.75
Maternal Dietary Vitamin D Does Not Program Systemic Inflammation and Bone Health in Adult Female Mice Fed an Obesogenic Diet. Nutrients (2016) 0.75
Diabetes and osteoporotic fractures. CMAJ (2007) 0.75
Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord (2016) 0.75
Clinical performance of an updated trabecular bone score (TBS) algorithm in men and women: the Manitoba BMD cohort. Osteoporos Int (2017) 0.75
Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada. Osteoporos Int (2017) 0.75
Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study. Osteoporos Int (2016) 0.75
Traumatic Facial Injuries Among Elderly Nursing Home Residents: Never Event or Frequent Occurrence? JAMA Otolaryngol Head Neck Surg (2017) 0.75
Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong. Osteoporos Int (2016) 0.75
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser (1994) 17.37
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Assessment of fracture risk. Osteoporos Int (2004) 5.15
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int (2001) 2.94
A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res (2004) 2.92
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J (2005) 2.15
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int (2004) 1.60
Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res (2005) 1.56
An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med (2004) 1.48
Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab (2006) 1.39
Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J (2007) 1.32
Construction and validation of a population-based bone densitometry database. J Clin Densitom (2005) 1.24
Short-term mortality after repair of hip fracture. Do Manitoba elderly do worse? Med Care (1996) 1.10
Guidelines for the diagnosis of osteoporosis: T-scores vs fractures. Rev Endocr Metab Disord (2006) 1.08
Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom (2003) 1.00
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res (2004) 1.00
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA (2003) 8.47
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr (2008) 3.33
Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA (2008) 3.25
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA (2003) 3.03
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol (2006) 2.74
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2008) 2.57
Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med (2012) 2.54
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res (2011) 2.24
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol (2012) 2.24
Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med (2014) 2.20
Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol (2008) 2.19
AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology (2003) 2.17
Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J (2005) 2.15
Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol (2008) 2.04
The 2002 Canadian bone densitometry recommendations: take-home messages. CMAJ (2002) 1.92
Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol (2009) 1.90
Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care (2002) 1.88
Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res (2014) 1.86
Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem (2009) 1.85
FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res (2012) 1.82
Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr (2005) 1.80
Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest (2003) 1.77
Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am (2006) 1.72
Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia. Diabetes Res Clin Pract (2010) 1.71
Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab (2003) 1.65
The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care (2007) 1.61
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ (2010) 1.59
Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology (2009) 1.59
Relationship Among Body Fat Percentage, Body Mass Index, and All-Cause Mortality: A Cohort Study. Ann Intern Med (2016) 1.56
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol (2008) 1.55
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55
The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism (2003) 1.49
Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol (2003) 1.48
Therapy insight: Osteoporosis in inflammatory bowel disease--advances and retreats. Nat Clin Pract Gastroenterol Hepatol (2005) 1.48
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study. J Rheumatol (2013) 1.44
Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab (2006) 1.39
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res (2010) 1.37
Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. Can Assoc Radiol J (2007) 1.32
Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med (2004) 1.29
FRAX(®) with and without bone mineral density. Calcif Tissue Int (2011) 1.29
Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res (2007) 1.28
Canadian Aboriginal women have a higher prevalence of vitamin D deficiency than non-Aboriginal women despite similar dietary vitamin D intakes. J Nutr (2007) 1.27
10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med (2008) 1.20
Association between change in BMD and fragility fracture in women and men. J Bone Miner Res (2009) 1.19
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom (2004) 1.18
Retracted Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care (2011) 1.17
The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol (2003) 1.17
Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom (2007) 1.15
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol (2008) 1.13
Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res (2009) 1.13
Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ (2010) 1.12
Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health (2012) 1.11
Postfracture care for older women: gaps between optimal care and actual care. Can Fam Physician (2008) 1.11
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J (2011) 1.11
Socioeconomic status and the utilization of diagnostic imaging in an urban setting. CMAJ (2005) 1.09
Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program. Bone (2008) 1.07
Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials. Mayo Clin Proc (2002) 1.07
Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care (2012) 1.07
Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2004) 1.06
Fracture risk in living kidney donors: a matched cohort study. Am J Kidney Dis (2012) 1.06
Retracted Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis (2009) 1.05
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr (2002) 1.05
Adjusting fracture probability by trabecular bone score. Calcif Tissue Int (2015) 1.04
Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care (2007) 1.04
Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res (2010) 1.04
Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med (2007) 1.02
Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry (2006) 1.02
Parents bereaved by offspring suicide: a population-based longitudinal case-control study. JAMA Psychiatry (2013) 1.01
Bone scan findings in metastatic calcification from calciphylaxis. Clin Nucl Med (2008) 1.01
Vertebral fracture status and the World Health Organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res (2009) 1.00
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone (2008) 1.00
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice. J Clin Densitom (2011) 1.00
Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr (2006) 1.00
The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone (2008) 0.99
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99